(Q37328507)

English

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial

scientific article published on March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial (English)

1 reference

Europe PubMed Central

19 August 2017

0 references

Heart failure with preserved ejection fraction

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

Eugene Braunwald

30

object named as

Eugene Braunwald

1 reference

Europe PubMed Central

19 August 2017

Douglas L. Mann

object named as

Douglas L Mann

10

0 references

Adrian F. Hernandez

object named as

Adrian F Hernandez

28

0 references

Kevin J Anstrom

27

object named as

Kevin J Anstrom

1 reference

Europe PubMed Central

19 August 2017

Christopher M O'Connor

15

object named as

Christopher M O'Connor

1 reference

Europe PubMed Central

19 August 2017

16

object named as

G Michael Felker

1 reference

Europe PubMed Central

19 August 2017

Margaret M Redfield

1

object named as

Margaret M Redfield

1 reference

Europe PubMed Central

19 August 2017

8

object named as

Jean L Rouleau

1 reference

Europe PubMed Central

19 August 2017

Michael M Givertz

13

object named as

Michael M Givertz

1 reference

Europe PubMed Central

19 August 2017

Barry A Borlaug

3

object named as

Barry A Borlaug

1 reference

Europe PubMed Central

19 August 2017

Marc J Semigran

4

object named as

Marc J Semigran

1 reference

Europe PubMed Central

19 August 2017

18

object named as

Bradley A Bart

1 reference

Europe PubMed Central

19 August 2017

9

object named as

David A Bull

1 reference

Europe PubMed Central

19 August 2017

11

object named as

Anita Deswal

1 reference

Europe PubMed Central

19 August 2017

Alice M. Mascette

29

object named as

Alice M Mascette

1 reference

Europe PubMed Central

19 August 2017

20

object named as

Jenny C Ibarra

1 reference

Europe PubMed Central

19 August 2017

author name string

Horng H Chen

2

1 reference

Europe PubMed Central

19 August 2017

Kerry L Lee

5

1 reference

Europe PubMed Central

19 August 2017

Gregory Lewis

6

1 reference

Europe PubMed Central

19 August 2017

Martin M LeWinter

7

1 reference

Europe PubMed Central

19 August 2017

Lynne W Stevenson

12

1 reference

Europe PubMed Central

19 August 2017

Elizabeth O Ofili

14

1 reference

Europe PubMed Central

19 August 2017

Steven R Goldsmith

17

1 reference

Europe PubMed Central

19 August 2017

Steven E McNulty

19

1 reference

Europe PubMed Central

19 August 2017

Grace Lin

21

1 reference

Europe PubMed Central

19 August 2017

Jae K Oh

22

1 reference

Europe PubMed Central

19 August 2017

Manesh R Patel

23

1 reference

Europe PubMed Central

19 August 2017

Raymond J Kim

24

1 reference

Europe PubMed Central

19 August 2017

Russell P Tracy

25

1 reference

Europe PubMed Central

19 August 2017

Eric J Velazquez

26

1 reference

Europe PubMed Central

19 August 2017

RELAX Trial

31

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

1 March 2013

1 reference

Europe PubMed Central

19 August 2017

The Journal of the American Medical Association

1 reference

Europe PubMed Central

19 August 2017

309

1 reference

Europe PubMed Central

19 August 2017

1268-1277

1 reference

Europe PubMed Central

19 August 2017

12

1 reference

Europe PubMed Central

19 August 2017

Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Pressure-overload magnitude-dependence of the anti-hypertrophic efficacy of PDE5A inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Epidemiology of diastolic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Cardiac resynchronization in chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

6 September 2017

Reference equations for the six-minute walk in healthy adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

28 September 2017

Effect of sildenafil in renal ischemia/reperfusion injury in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

26 June 2018

PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

2 September 2018

Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

2 September 2018

PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

2 September 2018

Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

2 September 2018

Chronotropic incompetence as a predictor of death among patients with normal electrograms taking beta blockers (metoprolol or atenolol).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

2 September 2018

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

2 September 2018

The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

2 September 2018

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

20 October 2018

Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3835156

3 December 2018

Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/23478662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/23478662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/23478662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23478662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Letter by Forfia and Borlaug regarding article, "Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study"

1 reference

https://pubmed.ncbi.nlm.nih.gov/23478662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sildenafil Treatment Prevents Glomerular Hypertension and Hyperfiltration in Rats with Renal Ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23478662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/JAMA.2013.2024

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37328507&oldid=1866499301"